The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030.
Yinzong XiaoMargaret E HellardAlexander J ThompsonChristopher SeamanJess HowellNick ScottPublished in: The Medical journal of Australia (2023)
Universal screening for hepatitis B will be cost-effective only if the cost of testing is kept low and people receive appropriate clinical management.
Keyphrases